CRP and non-small cell lung carcinoma: Fumihiro Shoji et al. studied the relationship between pretreatment c-reactive protein (CRP), neutrophil–lymphocyte ratio (NLR), and PNI and the efficacy and prognosis of immunotherapy in 102 patients with non-small cell lung cancer (NSCLC) [28].